What is the FAVN test and what is it for?

The FAVN test is not a paperwork requirement for export. It is the only objective, reproducible and internationally accepted method of verifying that your dog or cat has responded to the rabies vaccine with the antibody level that destination countries require as a condition of entry.

FAVN stands for Fluorescent Antibody Virus Neutralisation. What it measures is the actual capacity of your animal's serum to neutralise the rabies virus in cell culture. It does not measure whether the animal is vaccinated. It measures whether the vaccine worked.

Why does this test exist?

Rabies has a case fatality rate approaching 100% once clinical signs appear. Countries that have succeeded in eliminating it from their territory — Spain, France, Japan, Australia, New Zealand, the United Kingdom, most of the European Union — maintain that status through strict biosanitary barrier systems. One of the critical points in those systems is the international movement of companion animals.

An animal that travels with an incomplete vaccination or without a verified immune response can introduce the virus into an ecosystem that has been free of it for decades. The FAVN exists because vaccination alone is not a sufficient guarantee: not all animals respond equally, not all vaccines carry the same potency, and not all protocols are applied correctly.

The FAVN turns that guarantee into a measurable, reproducible number comparable across laboratories in different countries. That is precisely what international regulatory bodies need to make consistent decisions.

How does it work? From vaccine to antibody

To understand why the FAVN is done at a specific moment and not earlier, you need to understand what happens inside the body after vaccination. It is not instantaneous. It is a five-step sequence that takes between 21 and 30 days.

This sequence explains why drawing blood on day 10 or day 20 can produce a negative result in an animal that would have passed perfectly at day 30. The 30-day window is not arbitrary: it is the minimum interval that science documents as necessary for IgG consolidation to be reliable in most animals.

The 0.50 IU/mL threshold: what it means and what it does not

The FAVN result is expressed in International Units per millilitre (IU/mL), calibrated against a WHO/WOAH reference serum. That standardisation means a result issued in Kansas is directly comparable with one issued in France or Japan, with no conversion.

A detail that pet owners rarely hear: an animal below the threshold is not necessarily undefended. Cellular immunity — T-lymphocytes — may contribute to resistance without being reflected in the FAVN. But for the purposes of international export, the neutralisation test result at an accredited laboratory is the only criterion destination countries accept. There is no documentary equivalent.

Why must you wait 30 days after vaccination?

The most frequent question I receive: "Can we do it earlier to save time?"

It does not work that way. Drawing blood before 30 days may capture a phase of the immune process where IgG antibodies have not yet matured. The result can be negative in an animal that would have passed perfectly two weeks later. You will have spent the cost of the test, the laboratory shipping time and the process margin — and you will have to repeat it.

EU Regulation 576/2013 sets that 30-day minimum post-primary vaccination precisely because scientific literature documents that a significant fraction of animals do not reach ≥ 0.5 IU/mL until the third or fourth week. It is not a number chosen arbitrarily by European bureaucracy: it is the interval that minimises the probability of a false negative due to incorrect timing.

Why can the FAVN fail if the animal is vaccinated?

This is the question that generates the most frustration when it happens. Vaccination and seroconversion are two different things. The vaccine initiates the process — but the outcome depends on several factors the veterinarian must evaluate before designing the protocol.

Scientific literature documents the following causes of primary serological failure, in order of documented frequency:

• ⚠
  Vaccination without documented booster — The most frequent cause per Wallace et al. (2017) in the largest published analysis of primary rabies vaccination outcomes (n = 8,011). A single dose without a prior booster does not guarantee an anamnestic response. Unverifiable vaccination history produces the same result.
• ⚠
  Blood draw before 30 days — IgG has not matured. The animal may pass perfectly at 30 days. The timing of extraction is as important as the vaccination protocol.
• ·
  Age under one year — Residual maternal antibodies can interfere with the primary response. Kennedy et al. (2007) identified age under 1 year as a significant risk factor in a dataset of over 10,000 dogs.
• ·
  Large breeds — Consistently higher failure rates in large-breed dogs, possibly due to differences in antigen distribution relative to body mass (Kennedy et al. 2007; Berndtsson et al. 2011).
• ·
  Active immunosuppressive disease — Hyperadrenocorticism (Cushing's), leishmaniasis, malnutrition or any condition compromising immune response can attenuate seroconversion. Clinical evaluation before export vaccination is not optional.
• ·
  Corticosteroids or immunosuppressants — Animals on treatment at the time of vaccination may not mount an adequate response.
• ·
  Compromised cold chain — Inactivated rabies vaccines must be maintained at 2–8°C. A vaccine exposed to incorrect temperature may have no immunogenic activity. Batch and storage condition verification are part of the protocol.

What to do when the result is FAIL

A FAIL result does not mean the process ends. It means it must be restarted with the correct protocol. The standard reconversion protocol is D1/D15/D30 with Novibac Rabies.

The immunological rationale is precise: the booster on D15 — when memory B-lymphocytes are fully primed but the primary response has not yet declined — generates a high-magnitude anamnestic response. The blood draw on D30, 16 days after the booster, captures that peak in its consolidation. This is the design that maximises the probability of PASS on the second test.

Under EU Regulation 576/2013, a FAIL result means restarting the 30-day count from the new primary vaccination, plus the 3-month pre-movement waiting period from the new sampling date. Under CDC rules for the United States, revaccination and a new sample at ≥ 30 days are required to avoid 28-day quarantine on arrival.

This has real consequences for travel timelines. Which is why the prior clinical evaluation — verifiable vaccination history, immune status, age, breed — is not a formality: it is the difference between a process that runs on time and one that is delayed by months.

RFFIT and FAVN: two names for the same test

If you have researched rabies serology, you will have seen both terms. The technical difference is minor and regulatorily irrelevant: both tests measure rabies virus-neutralizing antibodies by cytopathic effect reduction, express the result in IU/mL against the same WHO/WOAH reference serum, and are accepted as equivalent by all international bodies.

The practical difference: RFFIT requires live virus (CVS-11 strain) in BSL-2/3 biosafety conditions and is the historical reference method in North American laboratories. FAVN, developed in 1998 at ANSES Nancy (now the European Union Reference Laboratory for rabies), uses a fixed strain under slightly more standardised conditions and has become the predominant method in approved European laboratories.

If your veterinarian in another country mentions RFFIT and we refer to FAVN here — it is the same test, the same regulatory consequences, the same 0.50 IU/mL threshold. You do not need both. One result from a WOAH-accredited laboratory is sufficient for all destinations.

Scientific publications this page is based on

This content is written from direct clinical practice in international pet export and from the following open-access publications with verifiable DOIs: